Sequanta has built an integrated proteomics detecticn center featuring high throughput, high sensitivity, and multi-scenario applications. We are committed to providing world-class data support for biopharmaceutical R&D and precision medicine.
Integrating three world-leading platforms: Olink (PEA), Alamar(NULISA), and SomaLogic (SomaScan). We provide optimal technology path matching based on research objectives, achieving full-process coverage from high-throughput screening to ultra-high sensitivity detection and precision validation.
Centering on scientific and clinical questions, we provide end-to-end experimental design services to ensure thatplatform selection, panel configuration, and research goalsare highly aligned, maximizing the output value of biochemical data.
We have constructed a customized data analysis workflow supporting differential analysis, pathway enrichment, andmachine learning modeling, as well as multi-omics integration(Proteomics + Genomics/Transcriptomics) to uncover transformable biological insights from data.
Relying on CAP/CLIA/ISO certified laboratories and platform validation systems, we ensure data quality meets global pharmaceutical enterprise and regulatory agency standards,strongly supporting the implementation of drug clinical trials.
We provide end-to-end support-from scheme design and experimental execution to data analysis and project applicationassistance-helping clients efficiently advance biomarker development and clinical translation.
